Survival curves.

<p><b>Survival rate (percentage of subjects without MS episode) from the occurrence of the component, in accordance with the first occurrence of components related to glucose metabolism, combined with dyslipidaemia.</b> The horizontal line represents a 50% probability (of the first MS episode occurring).</p

Baseline characteristics of participants who developed one or more than one metabolic syndrome episode.

<p>Baseline characteristics of participants who developed one or more than one metabolic syndrome episode.</p

Risk of the first episode of metabolic syndrome in relation to the occurrence of the first two components.

<p>Multivariate analysis.</p

Variables related to the risk of persistent or non-persistent metabolic syndrome.

<p>Multivariate analysis.</p

Variables related to the risk of the occurrence of the first episode of metabolic syndrome and to the risk of the occurrence of any episode of metabolic syndrome.

<p>Multivariate analyses.</p

Order in which the components appear and risk first metabolic syndrome episode.

<p>Order in which the components appear and risk first metabolic syndrome episode.</p

Baseline characteristics of cohort participants, 1/1/2005.

<p>Baseline characteristics of cohort participants, 1/1/2005.</p

Characteristics of participants at the moment of the first episode of metabolic syndrome, according to persistence or discontinuity.

<p>Characteristics of participants at the moment of the first episode of metabolic syndrome, according to persistence or discontinuity.</p

Patients’ characteristics with respect to glomerular filtration rate (eGFR).

<p>Patients’ characteristics with respect to glomerular filtration rate (eGFR).</p

Association of chronic kidney disease and diabetic retinopathy.

<p>*Adjusted by sex, age at digital photography, duration of type 2 diabetes, systolic blood pressure <140 mmHg, and A1C ≤7%; DR, diabetic retinopathy; eGFR, estimated glomerular filtration rate; UACR, urine albumin to creatinine ratio; VTDR, vision threatening diabetic retinopathy (severe non proliferative DR, proliferative DR, and diabetic macular edema); non-VTDR, mild non-proliferative DR and moderate non-proliferative DR.</p